ALPHAMET

This brand name is authorized in Nigeria.

Active ingredients

The drug ALPHAMET contains one active pharmaceutical ingredient (API):

1	Alphamethyldopa UNII 56LH93261Y - METHYLDOPA
	Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
	Read more about Alphamethyldopa

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4976	Tablet	ALPHAMET 250 TABLETS TAB 250 mg 6x10, 10x10	ALPHAMET 250 TABLETS METHYLDOPA 250MG TABLET Methyldopa 250mg, polyvidone, sodium edetate, magnesium stearate, crospovidone, precipitated silica, macrogol, talc B4-4976 Drugs Imported Products 6x10, 10x10 Prescription Only Medicine (POM) 26/06/2020 GRACE DRUGS & HEALTHCARE LIMITED, OGUNLANA DRIVE, SURULERE LAGOS 8104638301 grace_drugs@hotmail.com SHANDONG XIER KANGTAI PHARMACEUTICAL CO. , LTD., PRIVATE ECONOMY GARDEN, XINYAN TOWN, YANZHOU, JINING CITY, SHANDONG. CHINA., China	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02AB01	Methyldopa (levorotatory)	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4976